Mylan has been fighting for more than a year to block Teva’s generic EpiPen. But all along EpiPen itself has been classified as a generic drug for Medicaid…

Plenty of drugmakers, including Shire and J&J, market ADHD drugs for children. But those drugs may not help kids do their homework or get better grades, a…

A dozen specialty pharmacies made it to this year’s Inc. magazine list of fastest growing private companies in the U.S., including one in the top 10.

Pfizer’s vaccines business has enjoyed tremendous growth, thanks to the superstar pneumococcal blocker Prevnar 13. But that growth could be tough to sustain,…

Sun Pharma licensed a home-grown dengue fever vaccine that it hopes will rival Sanofi's Dengvaxia, which was recently delayed in India.

McCann Health has launched a new consultancy, Consulting at McCann Health, with two objectives. The first: consolidate its health consulting agencies. And the…

A year can make a big difference in the outlook of the vaccines industry. Since issuing its World Preview report last year, analyst group EvaluatePharma has…

When Gilead's hep C drugs hit the market, their older rivals went into a tailspin. Now, it's Gilead's time to suffer. The hep C market is once…